Key result
Lowering apoCIII in high-fat diet-fed mice decreased adipocyte size, reduced inflammatory cytokine expression, and normalized insulin-induced inhibition of lipolysis in white adipose tissue.
Why the study?
ApoCIII is proinflammatory and increases in HFD-induced obesity, but its specific effects on subcutaneous and visceral white adipose tissue were unknown.
Does reducing apoCIII with antisense oligonucleotides prevent or reverse high-fat diet-induced inflammation and insulin resistance in white adipose tissue in mice?
Does reducing apoCIII with antisense oligonucleotides prevent or reverse high-fat diet-induced inflammation and insulin resistance in white adipose tissue in mice?
Lowering apoCIII prevents and reverses high-fat diet-induced metabolic derangements and inflammation in white adipose tissue in a mouse model.
Answers are grounded in this paper and cite their sources.
Preclinical apoCIII reduction improves adipose inflammation and insulin sensitivity in mice; leaves open human therapeutic translation.
Apolipoprotein CIII (apoCIII) is proinflammatory and increases in high-fat diet (HFD)-induced obesity and insulin resistance. We have previously shown that reducing apoCIII improves insulin sensitivity in vivo by complex mechanisms involving liver and brown adipose tissue. In this study the focus was on subcutaneous (SAT) and visceral (VAT) white adipose tissue (WAT). Mice were either given HFD for 14 weeks and directly from start also treated with antisense oligonucleotide (ASO) against apoCIII or given HFD for 10 weeks and HFD+ASO for an additional 14 weeks. Both groups had animals treated with inactive (Scr) ASO as controls and in parallel chow-fed mice were injected with saline. Preventing an increase or lowering apoCIII in the HFD-fed mice decreased adipocytes' size, reduced expression of inflammatory cytokines and increased expression of genes related to thermogenesis and beiging. Isolated adipocytes from both VAT and SAT from the ASO-treated mice had normal insulin-induced inhibition of lipolysis compared to cells from Scr-treated mice. In conclusion, the HFD-induced metabolic derangements in WATs can be prevented and reversed by lowering apoCIII.
No takes yet. Share an insight, caveat, or question.
Recio‐López et al. (2021) studied Obesity-induced inflammation and insulin resistance. Antisense oligonucleotide (ASO) against apoCIII vs. Inactive (Scr) ASO and saline was evaluated on Adipocyte size, inflammatory cytokine expression, and insulin-induced inhibition of lipolysis. Lowering apoCIII in high-fat diet-fed mice decreased adipocyte size, reduced inflammatory cytokine expression, and normalized insulin-induced inhibition of lipolysis in white adipose tissue.
Synapse has enriched 10 related papers. Consider them for comparative context: